Mourad W. Ali

599 total citations
20 papers, 408 citations indexed

About

Mourad W. Ali is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Mourad W. Ali has authored 20 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Mourad W. Ali's work include Epigenetics and DNA Methylation (6 papers), Genetic factors in colorectal cancer (6 papers) and Cancer-related gene regulation (6 papers). Mourad W. Ali is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Genetic factors in colorectal cancer (6 papers) and Cancer-related gene regulation (6 papers). Mourad W. Ali collaborates with scholars based in United States, Spain and China. Mourad W. Ali's co-authors include Shelley B. Hooks, Susanna F. Greer, Ercan Çaçan, Nathaniel Boyd, Mandi M. Murph, Molly K. Altman, Jillian H. Hurst, Ruchi Yadav, Graham Casey and Mei Gao and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Human Molecular Genetics.

In The Last Decade

Mourad W. Ali

20 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mourad W. Ali United States 11 272 79 66 50 37 20 408
Mari Merentie Finland 13 322 1.2× 62 0.8× 52 0.8× 52 1.0× 28 0.8× 17 547
Dong Guo China 12 294 1.1× 105 1.3× 58 0.9× 32 0.6× 24 0.6× 31 458
Eileen Vesely United States 7 328 1.2× 83 1.1× 48 0.7× 69 1.4× 28 0.8× 8 486
Claudia M Weller Netherlands 12 174 0.6× 64 0.8× 65 1.0× 56 1.1× 82 2.2× 16 440
Tibor Gyuris United States 10 327 1.2× 72 0.9× 80 1.2× 50 1.0× 26 0.7× 14 461
Hyoung Oh Jun South Korea 14 302 1.1× 80 1.0× 96 1.5× 33 0.7× 18 0.5× 19 503
Hui‐Jun Mu China 13 220 0.8× 61 0.8× 83 1.3× 63 1.3× 26 0.7× 32 434
Mingqi Qu China 12 420 1.5× 93 1.2× 50 0.8× 36 0.7× 21 0.6× 17 611
Hongyun Zheng China 14 213 0.8× 111 1.4× 43 0.7× 67 1.3× 56 1.5× 24 451

Countries citing papers authored by Mourad W. Ali

Since Specialization
Citations

This map shows the geographic impact of Mourad W. Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mourad W. Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mourad W. Ali more than expected).

Fields of papers citing papers by Mourad W. Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mourad W. Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mourad W. Ali. The network helps show where Mourad W. Ali may publish in the future.

Co-authorship network of co-authors of Mourad W. Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Mourad W. Ali. A scholar is included among the top collaborators of Mourad W. Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mourad W. Ali. Mourad W. Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devall, Matthew A.M., Mourad W. Ali, Daniel J. Weisenberger, et al.. (2023). Multi‐omic analysis in normal colon organoids highlightsMSH4as a novel marker of defective mismatch repair in Lynch syndrome and microsatellite instability. Cancer Medicine. 12(12). 13551–13572. 9 indexed citations
2.
Devall, Matthew A.M., Christopher H. Dampier, Mourad W. Ali, et al.. (2022). Transcriptomic Response to Calcium in Normal Colon Organoids is Impacted by Colon Location and Sex. Cancer Prevention Research. 15(10). 679–688. 4 indexed citations
3.
Devall, Matthew A.M., Mourad W. Ali, Christopher H. Dampier, et al.. (2022). DNA methylation analysis of normal colon organoids from familial adenomatous polyposis patients reveals novel insight into colon cancer development. Clinical Epigenetics. 14(1). 104–104. 14 indexed citations
4.
Ali, Mourad W., Jianhong Chen, Li Yan, et al.. (2022). A risk variant for Barrett’s esophagus and esophageal adenocarcinoma at chr8p23.1 affects enhancer activity and implicates multiple gene targets. Human Molecular Genetics. 31(23). 3975–3986. 3 indexed citations
5.
Devall, Matthew A.M., et al.. (2022). Insights into Early Onset Colorectal Cancer through Analysis of Normal Colon Organoids of Familial Adenomatous Polyposis Patients. Cancers. 14(17). 4138–4138. 4 indexed citations
6.
Ali, Mourad W., Matthew A.M. Devall, Christopher H. Dampier, et al.. (2021). A Functional Variant on 9p21.3 Related to Glioma Risk Affects Enhancer Activity and Modulates Expression of CDKN2B‐AS1. Human Mutation. 42(10). 1208–1214. 7 indexed citations
7.
Devall, Matthew A.M., Christopher H. Dampier, Mourad W. Ali, et al.. (2021). Novel insights into the molecular mechanisms underlying risk of colorectal cancer from smoking and red/processed meat carcinogens by modeling exposure in normal colon organoids. Oncotarget. 12(19). 1863–1877. 8 indexed citations
8.
Fortini, Barbara K., et al.. (2021). SNPs associated with colorectal cancer at 15q13.3 affect risk enhancers that modulate GREM1 gene expression. Human Mutation. 42(3). 237–245. 12 indexed citations
9.
Chen, Jianhong, Mourad W. Ali, Li Yan, et al.. (2021). Prioritization and functional analysis of GWAS risk loci for Barrett’s esophagus and esophageal adenocarcinoma. Human Molecular Genetics. 31(3). 410–422. 6 indexed citations
10.
Ali, Mourad W., Jacqueline Jufen Zhu, Christopher H. Dampier, et al.. (2020). A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes. Human Mutation. 42(1). 77–88. 13 indexed citations
12.
Lange, Ingo, et al.. (2017). FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways. Oncotarget. 8(66). 109985–109999. 15 indexed citations
14.
Alqinyah, Mohammed, Mourad W. Ali, Ruchi Yadav, et al.. (2016). Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity. Molecular Pharmacology. 91(3). 197–207. 30 indexed citations
17.
Çaçan, Ercan, Mourad W. Ali, Nathaniel Boyd, Shelley B. Hooks, & Susanna F. Greer. (2014). Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance. PLoS ONE. 9(1). e87455–e87455. 83 indexed citations
18.
Ali, Mourad W., Ercan Çaçan, Yuying Liu, et al.. (2013). Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells. PLoS ONE. 8(3). e60185–e60185. 43 indexed citations
19.
20.
Hooks, Shelley B., et al.. (2010). Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Molecular Cancer. 9(1). 289–289. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026